Streetbeat News

Products Services

AA

Alcoa Corporation (NYSE:AA) reported Q4 losses of $0.56 per share, beating analyst estimates but with a year-over-year increase in losses. Sales fell short of expectations at $2.60 billion, a slight decrease from the previous year. Alumina production dropped 1%, while Aluminum production increased by 2%. The company provided a 2024 forecast for Alumina production and shipments. Despite the mixed results and positive outlook, Alcoa's stock fell by 2.79% in after-hours trading.

Portfolio Pulse from Ryan Gustafson

January 17, 2024 | 9:44 pm

XPON

Expion360 has introduced its new GC2 and Group 27 Series LiFePO4 batteries, which incorporate proprietary Vertical Heat Conduction technology, Bluetooth and CAN Bus communication, and breakthrough cell technology that boosts energy density by up to 32%. This advancement in power technology represents a significant step forward for the company.

Portfolio Pulse from Benzinga Newsdesk

January 17, 2024 | 9:22 pm

NVRO

Nevro Corp. (NYSE:NVRO) will present 25 scientific abstracts at the 2024 North American Neuromodulation Society Annual Meeting, highlighting the clinical results of its 10 kHz Therapy for chronic pain treatment. The company will also showcase its AI-enabled HFX iQ system and unveil a new sacroiliac joint fusion portfolio. Nevro's CEO, Kevin Thornal, emphasized the company's commitment to improving chronic pain management and the substantial benefits of their therapy.

Portfolio Pulse from Benzinga Newsdesk

January 17, 2024 | 9:20 pm

FNKO

Funko has entered into a global deal with Goliath, where Goliath will acquire assets of Funko's board game studio and design team. The deal includes Goliath becoming the exclusive worldwide distributor of Funko's games and puzzles, and involves an initial payment and future royalty payments to Funko. Financial terms of the deal were not disclosed.

Portfolio Pulse from Benzinga Newsdesk

January 17, 2024 | 9:17 pm

NYXH

Nyxoah SA (NASDAQ:NYXH), a medical technology company, announced its 2024 strategic priorities, including completing patient follow-up in the DREAM U.S. pivotal study and reporting data by early April. Preliminary data showed positive efficacy and safety results. The company plans to file the final module of its PMA submission after the DREAM results, prepare for a late 2024 U.S. launch, complete enrollment in the ACCCESS study, and increase market penetration in Europe. Nyxoah's Genio system has been successful in Europe and is expected to replicate this success in the U.S.

Portfolio Pulse from Benzinga Newsdesk

January 17, 2024 | 9:16 pm

BROS

Dutch Bros Inc. (NYSE:BROS) announced plans to expand its operations support center in Phoenix, Arizona, with the intention to relocate approximately 40% of its total support staff there by January 1, 2025. The move is strategic, aiming to strengthen the company's operations as it targets a long-term goal of over 4,000 shops. CEO Christine Barone highlighted the importance of relationships and connectivity for the brand's growth. The company will provide more details in its Q4 and Full-Year 2023 earnings call. Despite the expansion, Dutch Bros will maintain a significant presence in Grants Pass, Oregon, including its roasting facility and several support operations.

Portfolio Pulse from Benzinga Newsdesk

January 17, 2024 | 9:15 pm

TSLA

UBER

Uber Technologies Inc is collaborating with Tesla Inc to promote the adoption of electric vehicles (EVs) among Uber drivers. This partnership includes sharing data to improve charging infrastructure, offering test drives, and providing discounts on Tesla vehicles. Uber CEO Dara Khosrowshahi emphasized the need for collective efforts in electrification and remains committed to Uber's goal of an electric fleet by 2030 in the U.S., Canada, and Europe, and by 2040 globally. Despite a broader pullback in the EV industry, Uber is actively working with manufacturers like Tesla to make EVs more affordable for drivers.

Portfolio Pulse from Adam Eckert

January 17, 2024 | 9:11 pm

BTMD

Biote Corp. (NASDAQ:BTMD) has entered into a definitive agreement to acquire F.H. Investments, Inc., doing business as Asteria Health, for $8.5 million, with an additional $500,000 contingent on production metrics. Asteria Health is a 503B manufacturer of compounded bioidentical hormones and a current supplier to Biote-certified practitioners. The acquisition aims to enable vertical integration, improve Biote's margin profile, and expand product offerings. The deal is expected to close in Q1 2024 and is funded by Biote's cash reserves. Truist Securities is the financial advisor for the transaction.

Portfolio Pulse from Benzinga Newsdesk

January 17, 2024 | 9:09 pm

VOR

Vor Bio has dosed its first patient with VCAR33, a treatment for Acute Myeloid Leukemia (AML). This marks a significant milestone in the company's development of new therapies for AML.

Portfolio Pulse from Benzinga Newsdesk

January 17, 2024 | 9:02 pm

SONY

Matthew Gallant, director of 'The Last of Us Part 2: Remastered', defends the game's remastered version for PlayStation 5, set to release on Jan. 19. He addresses the backlash regarding its release close to the original, highlighting enhanced features and graphics. Sony's Naughty Dog offers a $10 upgrade for PS4 owners. The remaster includes new modes, developer commentary, graphical improvements, DualSense integration, and a Guitar Free Play mode. Gallant emphasizes the remaster's appeal to new PS5 owners and fans of the franchise.

Portfolio Pulse from Franca Quarneti

January 17, 2024 | 9:01 pm